Study objectives To determine whether the combination of ipratropium bromide and
albuterol results in greater and more consistent pulmonary function test (PFT) response …

This retrospective analysis of data from two multi-center, randomized, double-blind, parallel
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …

Objective Bronchodilators are routinely used in the long-term therapy of patients with COPD.
These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term …

Objective The GOLD guidelines suggest that the presence of a post-bronchodilator forced
expiratory volume in one second (FEV1)< 80% of the predicted value in combination with a …

Study objective We compared the long-term safety and efficacy of the combination
ipratropium bromide (IB) and albuterol sulfate (ALB) inhalation solution with that of each …

Background: A limited or absent bronchodilator response is used to classify chronic
obstructive pulmonary disease (COPD) and can determine the treatment offered. The …

Study objective To evaluate the impact of a week-long course of inhaled albuterol compared
with ipratropium on expiratory peak flow, exercise performance, and dyspnea in patients …

Background: Patients with symptoms of GOLD stage I chronic obstructive pulmonary disease
(COPD) can have significant abnormalities of ventilatory mechanics with greater exertional …

The degree of acute improvement in spirometric indices after bronchodilator inhalation
varies among chronic obstructive pulmonary disease (COPD) patients, and depends upon …

Background Debate continues as to whether acute bronchodilator responsiveness (BDR)
predicts long-term outcomes in COPD. Furthermore, there is no consensus on a threshold …